Lifeworks Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-16,019
Closed -$301K 234
2024
Q1
$301K Sell
16,019
-15,334
-49% -$263K 0.08% 180
2023
Q4
$452K Sell
31,353
-9,847
-24% -$134K 0.16% 124
2023
Q3
$715K Buy
41,200
+14,378
+54% +$300K 0.28% 97
2023
Q2
$558K Buy
26,822
+2,292
+9% +$49.8K 0.24% 100
2023
Q1
$577K Buy
24,530
+16,081
+190% +$432K 0.27% 98
2022
Q4
$236K Sell
8,449
-3,696
-30% -$94.5K 0.13% 104
2022
Q3
$318K Buy
12,145
+4,322
+55% +$130K 0.18% 100
2022
Q2
$264K Buy
+7,823
New +$274K 0.17% 111

Other funds holding OGN

Lifeworks Advisors's OGN Position: Q2 2024 in Review

Lifeworks Advisors sold out of Organon & Co (OGN) in Q2 2024, closing a stake of 16,019 shares — an estimated $301K sold.

Lifeworks Advisors first reported a position in OGN in Q2 2022 and held it in 8 quarters. The position peaked at $715K in Q3 2023. 724 funds tracked by Wall St. Rank hold OGN as of Q2 2024.

  • Lifeworks Advisors reported no remaining Organon & Co position as of Q2 2024 after selling out during the quarter.
  • Lifeworks Advisors sold 16,019 Organon & Co shares in Q2 2024, an estimated $301K.
  • Lifeworks Advisors first reported a position in Organon & Co in Q2 2022 and held it in 8 quarters.
  • Lifeworks Advisors's Organon & Co position peaked at $715K in Q3 2023.
  • 724 funds tracked by Wall St. Rank held Organon & Co as of Q2 2024.

Based on Lifeworks Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.